Posted by kinasepro on June 19, 2007
aka Ruboxistaurin / LY333531 is a Lilly PKC-b inhibitor
J Med Chem ’96; Org Lett ’01; Science ’96; clinic
This entry was posted on June 19, 2007 at 12:36 am and is filed under Lilly, Phase III, PKC.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.